Shubha Chungi

Title: Shubha Chungi: Innovator in Pharmaceutical Formulations

Introduction

Shubha Chungi is a notable inventor based in Sharon, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 3 patents, her work focuses on improving therapeutic outcomes for patients at elevated cardiovascular risk.

Latest Patents

One of her latest patents is a combination dosage form that includes individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin. This orally administrable pharmaceutical formulation is designed to provide a simple and convenient therapy to reduce the risk of cardiovascular events. It is particularly beneficial for individuals with systemic lupus erythematosus and those experiencing acute myocardial infarction. Another significant patent involves a pharmaceutical dosage form for the pulsatile delivery of methylphenidate. This innovative formulation allows for the release of the encapsulated drug in spaced-apart "pulses," enhancing the therapeutic efficacy of the medication.

Career Highlights

Shubha has worked with prominent companies in the pharmaceutical industry, including Teva Pharmaceuticals USA, Inc. and Armaquest, Inc. Her experience in these organizations has contributed to her expertise in drug formulation and delivery systems.

Collaborations

Throughout her career, Shubha has collaborated with esteemed colleagues such as Theodore L. Iorio and Kangwen Lin. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of pharmaceutical sciences.

Conclusion

Shubha Chungi's contributions to pharmaceutical formulations demonstrate her commitment to improving patient care through innovative solutions. Her patents reflect her dedication to addressing critical health challenges and enhancing therapeutic options for patients.